الصفحة الرئيسية>>Signaling Pathways>> Cancer Biology>>SOR-C13 (trifluoroacetate salt)

SOR-C13 (trifluoroacetate salt)

رقم الكتالوجGC52397

A peptide TRPV6 antagonist

Products are for research use only. Not for human use. We do not sell to patients.

SOR-C13 (trifluoroacetate salt) التركيب الكيميائي

الحجم السعر المخزون الكميّة
5 mg
70٫00
متوفر
10 mg
126٫00
متوفر
25 mg
277٫00
متوفر
50 mg
486٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

SOR-C13 is a peptide antagonist of transient receptor potential vanilloid 6 (TRPV6).1 It inhibits calcium flux in HEK293 cells expressing human TRPV6 (EC50 = 14 nM). SOR-C13 (400, 600, and 800 mg/kg) reduces tumor volume in an SKOV3 ovarian cancer mouse xenograft model.

1.Xue, H., Wang, Y., MacCormack, T.J., et al.Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft modelJ. Cancer9(17)3196-3207(2018)

مراجعات

Review for SOR-C13 (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SOR-C13 (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.